FdaApplication
BLA 761331
Identifiers
- fda_app_no: BLA761331
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2023-10-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WEZLANA | USTEKINUMAB-AUUB | 130MG/26ML (5MG/ML) | Injection |
1 product